Eight compact analysis systems evaluated for measuring total cholesterol.

We examined the analytical performance of eight compact systems for measuring total cholesterol: AccuMeter, Cobas Ready, Discovery f2, DT60, L-D-X, Reflotron, QCA, and Vision. We determined average bias at two decision levels, the mean absolute bias, and the percentage of results differing from the comparison method results by > 8.9% allowable total error limit for multiple reagent lots. Average bias was < 3% for all lots tested for AccuMeter, Discovery f2, and DT60, but > 3% for one or more lots or sample types tested with the other systems. Of results from each reagent lot, > 95% were within the 8.9% total error specifications with Discovery f2, DT60, and QCA, whereas the performance of L-D-X, Vision, and Reflotron depended on reagent lot and (or) sample type. Of all results from each lot tested with AccuMeter and Cobas Ready, > 5% exceeded the total allowable error limit. We determined imprecision for five systems: Cobas Ready, Discovery f2, and QCA had CVs < 3%, whereas CVs for AccuMeter and L-D-X were > 3% but < 5%.

[1]  K Y Liang,et al.  Serum cholesterol in young men and subsequent cardiovascular disease. , 1993, The New England journal of medicine.

[2]  J. Mckenney,et al.  Total error assessment of five methods for cholesterol screening. , 1993, Clinical chemistry.

[3]  S. Havas,et al.  Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program. , 1992, American journal of public health.

[4]  M. Stugaard,et al.  Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. , 1990, Scandinavian journal of clinical and laboratory investigation.

[5]  Prithipal Singh,et al.  A noninstrumented quantitative test system and its application for determining cholesterol concentration in whole blood. , 1990, Clinical chemistry.

[6]  K. Anderson,et al.  How reliably can compact chemistry analyzers measure lipids? , 1990, JAMA.

[7]  P. Bachorik,et al.  Cholesterol screening: comparative evaluation of on-site and laboratory-based measurements. , 1990, Clinical chemistry.

[8]  G R Warnick,et al.  Measurement of cholesterol, triglycerides, and HDL using compact analysis systems. , 1989, Clinics in laboratory medicine.

[9]  K. Schneider,et al.  Reflotron cholesterol measurement evaluated as a screening technique. , 1988, Clinical chemistry.

[10]  L. Dusenbury,et al.  Evaluation of a simple method for measuring blood cholesterol levels using non-laboratory observers. , 1988, The American journal of medicine.

[11]  P. Fischer,et al.  A clinician's guide to the office measurement of cholesterol. , 1988, JAMA.

[12]  I Hinberg,et al.  Near-patient testing. Quality of laboratory test results obtained by non-technical personnel in a decentralized setting. , 1988, American journal of clinical pathology.

[13]  T. L. Liem,et al.  Revised calibration of the Reflotron cholesterol assay evaluated. , 1988, Clinical chemistry.

[14]  V. Panz,et al.  Determination of Cholesterol and Triglycerides in Blood: A Comparison between Wet Chemistry Methods and a Dry Chemistry Analyser , 1988, Annals of clinical biochemistry.

[15]  L. Råstam,et al.  Measurement of blood cholesterol with the Reflotron analyzer evaluated. , 1988, Clinical chemistry.

[16]  R. Sherwin,et al.  Bias and precision of cholesterol analysis by physician's office analyzers. , 1987, Clinical chemistry.

[17]  E. Topić,et al.  Analytical performance of the Vision System evaluated. , 1987, Clinical chemistry.

[18]  H. von Schenck,et al.  Laboratory and field evaluation of three desktop instruments for assay of cholesterol and triglyceride. , 1987, Clinical chemistry.

[19]  M. Iosefsohn,et al.  Hemoglobin, electrolytes, and other major clinical laboratory analytes as measured with a physician's office analyzer, the Kodak DT60. , 1986, Clinical chemistry.

[20]  R. Ng,et al.  Evaluation of the Kodak Ektachem DT-60 analyzer. , 1986, Clinical chemistry.

[21]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.

[22]  Cholesterol analyzers. , 1990, Health devices.

[23]  G. Assmann,et al.  Comparison of the Reflectance Method (Reflotron® Reflectance Photometer) with the Absorbance Method (Automatic Analysers) for the Determination of Cholesterol , 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[24]  Wilfrid Joseph Dixon,et al.  Introduction to statistical analysis, 2nd ed. , 1957 .